$42.65
-1.50-3.4%
Last update: Nov 6, 9:12 AM

The average analyst price target for Amrize is $48.76, 16.4% above the current price. Of 14 analysts, 7 rate it Buy, 5 Hold and 2 Sell. Targets range from $32 to $62. The latest change came on Nov 2, 2026, when Oppenheimer lowered its price target on Amrize from $55 to $52 and kept an Outperform rating.
Price Target Range — 7 Quarters
Analyst Consensus — 14 Analysts
Rating Trend — Last 9 Months